This information was published on 2025-06-16T12:49:31 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2528171 |
| (220) |
06 Mar 2025
|
| (300) |
US, 09 Sep 2024, 98/740,258
|
| (511) (510) |
Class 5
Pharmaceutical preparations, namely, small-molecule drugs; Pharmaceutical and biologic preparations for use in the treatment of oncology-related diseases and disorders; Pharmaceutical and biologic preparations for use in the treatment of metabolic-related diseases and disorders; Pharmaceutical and biologic preparations for use in the treatment of endocrine-related diseases and disorders; Pharmaceutical and biologic preparations for use in the treatment of diabetes and obesity-related diseases and disorders; Peptides for pharmaceutical purposes Class 42 Pharmaceutical and biologic development services, namely, development of small-molecule drugs for use in humans; Pharmaceutical and biologic development services, namely, development of pharmaceutical and biologic preparations for the treatment of oncology-related diseases and disorders; Pharmaceutical and biologic development services, namely, development of pharmaceutical and biologic preparations for the treatment of metabolic-related diseases and disorders; Pharmaceutical and biologic development services, namely, development of pharmaceutical and biologic preparations for the treatment of endocrine-related diseases and disorders; Pharmaceutical and biologic development services, namely, development of pharmaceutical and biologic preparations for the treatment of diabetes and obesity-related diseases and disorders; Research and development services in the field of pharmaceutical and biologic preparations; Research and development services in the field of oncology-related diseases and disorders; Research and development services in the field of metabolic-related diseases and disorders; Research and development services in the field of endocrine-related diseases and disorders; Research and development services in the fields of diabetes and obesity-related diseases and disorders; Research and development services in the field of peptide pharmaceutical preparations; Providing medical and scientific research information in the field of small-molecule drugs; Providing medical and scientific research information in the field of clinical trials and post-market trials; Providing medical and scientific research information in the field of oncology, metabolic, endocrine, diabetes, and obesity-related diseases and disorders |
| (540) | TERNS |
| (550) | Word |
| (730) |
Terns Pharmaceuticals, Inc.
|
| (750) |
PHILLIPS ORMONDE FITZPATRICK
|
Find out more about publications on the About page.